retatrutide side effects trial results of once-weekly subcutaneous on weight and metabolic markers: A systematic review and meta-analysis of randomized controlled trials An experimental weight-loss drug from

The most common side effects are nausea, vomiting, bloating, constipation, and diarrhea

Phase 2 trials testing 9 mg, 10 mg, and 16 mg doses have shown promising results with weight loss potentially approaching 20% or higher at maximum doses

find out why the thin-fat Indian pattern makes organ protection a priority And in Indians, these changes often happen earlier than expected

Wegovy doses reach up to 7.2 mg, although 2.4 mg is the usual maintenance dose, and unlike Ozempic, it is licensed for weight loss in the UK

Natural remedies and supplements beyond the basics Beyond fiber, magnesium, and probiotics, several other natural approaches have evidence supporting their use for GLP-1 constipation

Dig Dis Sci 69 , 44374445 (2024)